Overview

Topical Tranexamic Acid After Intravitreal Injections

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.
Phase:
N/A
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Tranexamic Acid